Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Francis RJ, Katz SI, Ak G, Opitz I, Gudmundsson E, Blyth KG, Gupta A.

Lung Cancer. 2019 Apr;130:108-114. doi: 10.1016/j.lungcan.2018.11.033. Epub 2018 Nov 28. Review.

PMID:
30885330
2.

Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software.

Bellinge JW, Majeed K, Carr SS, Jones J, Hong I, Francis RJ, Schultz CJ.

J Nucl Cardiol. 2019 Jan 25. doi: 10.1007/s12350-018-01587-7. [Epub ahead of print]

PMID:
30684262
3.

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging.

Segard T, Morandeau LMJA, Dunne ML, Robinson JO, Murray RJ, Geelhoed EA, Francis RJ.

Intern Med J. 2019 Aug;49(8):1016-1022. doi: 10.1111/imj.14231.

PMID:
30667165
4.

Isolation and characterisation of alveolar type II pneumocytes from adult bovine lung.

Lee DF, Salguero FJ, Grainger D, Francis RJ, MacLellan-Gibson K, Chambers MA.

Sci Rep. 2018 Aug 9;8(1):11927. doi: 10.1038/s41598-018-30234-x.

5.

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification.

Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ.

J Nucl Cardiol. 2018 Oct;25(5):1774-1783. doi: 10.1007/s12350-018-1360-2. Epub 2018 Jul 10.

PMID:
29992525
6.

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Hofman MS, Murphy DG, Williams SG, Nzenza T, Herschtal A, Lourenco RA, Bailey DL, Budd R, Hicks RJ, Francis RJ, Lawrentschuk N.

BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.

PMID:
29726071
7.

Accuracy of Dose Calibrators for 68Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment.

Bailey DL, Hofman MS, Forwood NJ, O'Keefe GJ, Scott AM, van Wyngaardt WM, Howe B, Kovacev O, Francis RJ; ARTnet; the ProPSMA Trial Investigators.

J Nucl Med. 2018 Apr;59(4):636-638. doi: 10.2967/jnumed.117.202861. Epub 2018 Jan 11.

8.

68 Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting.

Segard T, Morandeau LM, Geelhoed EA, Francis RJ.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):57-63. doi: 10.1111/1754-9485.12638. Epub 2017 Jul 17.

PMID:
28714296
9.

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy.

Tan H, Joseph D, Loh NK, McCarthy M, Leong E, Siew T, Segard T, Morandeau L, Trevenen M, Francis RJ.

J Med Imaging Radiat Oncol. 2016 Jun;60(3):374-81. doi: 10.1111/1754-9485.12455. Epub 2016 Apr 20.

PMID:
27094471
10.

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma.

Nowak AK, Cook AM, McDonnell AM, Millward MJ, Creaney J, Francis RJ, Hasani A, Segal A, Musk AW, Turlach BA, McCoy MJ, Robinson BW, Lake RA.

Ann Oncol. 2015 Dec;26(12):2483-90. doi: 10.1093/annonc/mdv387. Epub 2015 Sep 18.

11.

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

Francis RJ, Segard T, Morandeau L, Lee YC, Millward MJ, Segal A, Nowak AK.

Lung Cancer. 2015 Oct;90(1):55-60. doi: 10.1016/j.lungcan.2015.07.015. Epub 2015 Jul 30.

PMID:
26259878
12.

Automated identification of abnormal respiratory ciliary motion in nasal biopsies.

Quinn SP, Zahid MJ, Durkin JR, Francis RJ, Lo CW, Chennubhotla SC.

Sci Transl Med. 2015 Aug 5;7(299):299ra124. doi: 10.1126/scitranslmed.aaa1233.

13.

ANKS6 is the critical activator of NEK8 kinase in embryonic situs determination and organ patterning.

Czarnecki PG, Gabriel GC, Manning DK, Sergeev M, Lemke K, Klena NT, Liu X, Chen Y, Li Y, San Agustin JT, Garnaas MK, Francis RJ, Tobita K, Goessling W, Pazour GJ, Lo CW, Beier DR, Shah JV.

Nat Commun. 2015 Jan 20;6:6023. doi: 10.1038/ncomms7023.

14.

A gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver.

Kao YH, Luddington OS, Culleton SR, Francis RJ, Boucek JA.

J Nucl Med Technol. 2014 Dec;42(4):265-8. doi: 10.2967/jnmt.114.145292. Epub 2014 Nov 13.

15.

Mycobacterium tuberculosis ESAT-6 is a leukocidin causing Ca2+ influx, necrosis and neutrophil extracellular trap formation.

Francis RJ, Butler RE, Stewart GR.

Cell Death Dis. 2014 Oct 16;5:e1474. doi: 10.1038/cddis.2014.394.

16.

Airway ciliary dysfunction and sinopulmonary symptoms in patients with congenital heart disease.

Garrod AS, Zahid M, Tian X, Francis RJ, Khalifa O, Devine W, Gabriel GC, Leatherbury L, Lo CW.

Ann Am Thorac Soc. 2014 Nov;11(9):1426-32. doi: 10.1513/AnnalsATS.201405-222OC.

PMID:
25302410
17.

Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.

Armato SG 3rd, Nowak AK, Francis RJ, Kocherginsky M, Byrne MJ.

J Thorac Oncol. 2014 Aug;9(8):1187-94. doi: 10.1097/JTO.0000000000000211.

18.

Decellularized tracheal extracellular matrix supports epithelial migration, differentiation, and function.

Kutten JC, McGovern D, Hobson CM, Luffy SA, Nieponice A, Tobita K, Francis RJ, Reynolds SD, Isenberg JS, Gilbert TW.

Tissue Eng Part A. 2015 Jan;21(1-2):75-84. doi: 10.1089/ten.TEA.2014.0089. Epub 2014 Sep 12.

19.

Mycobacterium mimicking metastatic melanoma.

Teh RW, Feeney K, Francis RJ, Phillips M, Millward MJ.

Intern Med J. 2013 Dec;43(12):1342-6. doi: 10.1111/imj.12209. Review.

PMID:
24330366
20.

Ion Torrent sequencing for conducting genome-wide scans for mutation mapping analysis.

Damerla RR, Chatterjee B, Li Y, Francis RJ, Fatakia SN, Lo CW.

Mamm Genome. 2014 Apr;25(3-4):120-8. doi: 10.1007/s00335-013-9494-7. Epub 2013 Dec 5.

21.

Wdpcp, a PCP protein required for ciliogenesis, regulates directional cell migration and cell polarity by direct modulation of the actin cytoskeleton.

Cui C, Chatterjee B, Lozito TP, Zhang Z, Francis RJ, Yagi H, Swanhart LM, Sanker S, Francis D, Yu Q, San Agustin JT, Puligilla C, Chatterjee T, Tansey T, Liu X, Kelley MW, Spiliotis ET, Kwiatkowski AV, Tuan R, Pazour GJ, Hukriede NA, Lo CW.

PLoS Biol. 2013 Nov;11(11):e1001720. doi: 10.1371/journal.pbio.1001720. Epub 2013 Nov 26.

22.

Quality control of oblique incidence optical coatings based on normal incidence measurement data.

Amotchkina TV, Trubetskov MK, Tikhonravov AV, Schlichting S, Ehlers H, Ristau D, Death D, Francis RJ, Pervak V.

Opt Express. 2013 Sep 9;21(18):21508-22. doi: 10.1364/OE.21.021508.

PMID:
24104026
23.

Ca²⁺ and calpain control membrane expansion during the rapid cell spreading of neutrophils.

Dewitt S, Francis RJ, Hallett MB.

J Cell Sci. 2013 Oct 15;126(Pt 20):4627-35. doi: 10.1242/jcs.124917. Epub 2013 Aug 13.

24.

Imaging techniques for visualizing and phenotyping congenital heart defects in murine models.

Liu X, Tobita K, Francis RJ, Lo CW.

Birth Defects Res C Embryo Today. 2013 Jun;99(2):93-105. doi: 10.1002/bdrc.21037. Review.

25.

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres.

Kao YH, Steinberg JD, Tay YS, Lim GK, Yan J, Townsend DW, Budgeon CA, Boucek JA, Francis RJ, Cheo TS, Burgmans MC, Irani FG, Lo RH, Tay KH, Tan BS, Chow PKh, Satchithanantham S, Tan AE, Ng DC, Goh AS.

EJNMMI Res. 2013 Jul 25;3(1):57. doi: 10.1186/2191-219X-3-57.

26.

Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.

Segard T, Robins PD, Yusoff IF, Ee H, Morandeau L, Campbell EM, Francis RJ.

Clin Nucl Med. 2013 Jan;38(1):1-6. doi: 10.1097/RLU.0b013e3182708777.

PMID:
23242037
27.

Ca2+ activation of cytosolic calpain induces the transition from apoptosis to necrosis in neutrophils with externalized phosphatidylserine.

Francis RJ, Kotecha S, Hallett MB.

J Leukoc Biol. 2013 Jan;93(1):95-100. doi: 10.1189/jlb.0412212. Epub 2012 Oct 22.

PMID:
23089743
28.

A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma.

Nowak AK, Millward MJ, Creaney J, Francis RJ, Dick IM, Hasani A, van der Schaaf A, Segal A, Musk AW, Byrne MJ.

J Thorac Oncol. 2012 Sep;7(9):1449-56. doi: 10.1097/JTO.0b013e31825f22ee.

29.

Congenital heart disease and the specification of left-right asymmetry.

Francis RJ, Christopher A, Devine WA, Ostrowski L, Lo C.

Am J Physiol Heart Circ Physiol. 2012 May 15;302(10):H2102-11. doi: 10.1152/ajpheart.01118.2011. Epub 2012 Mar 9.

30.

Optical characterization and reverse engineering based on multiangle spectroscopy.

Tikhonravov AV, Amotchkina TV, Trubetskov MK, Francis RJ, Janicki V, Sancho-Parramon J, Zorc H, Pervak V.

Appl Opt. 2012 Jan 10;51(2):245-54.

PMID:
22270522
31.

A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment.

Nowak AK, Francis RJ, Katz SI, Gerbaudo VH.

PET Clin. 2011 Jul;6(3):299-311. doi: 10.1016/j.cpet.2011.04.002.

PMID:
27156725
32.

Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.

Gerbaudo VH, Katz SI, Nowak AK, Francis RJ.

PET Clin. 2011 Jul;6(3):275-97. doi: 10.1016/j.cpet.2011.04.001. Epub 2011 Jun 14.

PMID:
27156724
33.

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ, Nowak AK.

Clin Cancer Res. 2011 Mar 1;17(5):1181-9. doi: 10.1158/1078-0432.CCR-10-1929. Epub 2010 Dec 21.

34.

Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.

Nowak AK, Armato SG 3rd, Ceresoli GL, Yildirim H, Francis RJ.

Lung Cancer. 2010 Oct;70(1):1-6. doi: 10.1016/j.lungcan.2010.05.016. Epub 2010 Jun 11. Review.

PMID:
20541834
35.

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.

Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J, Musk AW, McCoy MJ, Segal A, Robins P, Byrne MJ.

Clin Cancer Res. 2010 Apr 15;16(8):2409-17. doi: 10.1158/1078-0432.CCR-09-2313. Epub 2010 Apr 6.

36.

Connexin 43 regulates epicardial cell polarity and migration in coronary vascular development.

Rhee DY, Zhao XQ, Francis RJ, Huang GY, Mably JD, Lo CW.

Development. 2009 Sep;136(18):3185-93. doi: 10.1242/dev.032334.

37.

Initiation and maturation of cilia-generated flow in newborn and postnatal mouse airway.

Francis RJ, Chatterjee B, Loges NT, Zentgraf H, Omran H, Lo CW.

Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L1067-75. doi: 10.1152/ajplung.00001.2009. Epub 2009 Apr 3.

38.

Assessment of tumour response with (18)F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax--a phantom study.

Boucek JA, Francis RJ, Jones CG, Khan N, Turlach BA, Green AJ.

Phys Med Biol. 2008 Aug 21;53(16):4213-30. doi: 10.1088/0031-9155/53/16/001. Epub 2008 Jul 24.

PMID:
18653927
39.

Heterotaxy and complex structural heart defects in a mutant mouse model of primary ciliary dyskinesia.

Tan SY, Rosenthal J, Zhao XQ, Francis RJ, Chatterjee B, Sabol SL, Linask KL, Bracero L, Connelly PS, Daniels MP, Yu Q, Omran H, Leatherbury L, Lo CW.

J Clin Invest. 2007 Dec;117(12):3742-52.

40.

Semiautomatic volume of interest drawing for (18)F-FDG image analysis-method and preliminary results.

Green AJ, Francis RJ, Baig S, Begent RH.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):393-406. Epub 2007 Oct 2.

PMID:
17909793
41.

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

Francis RJ, Byrne MJ, van der Schaaf AA, Boucek JA, Nowak AK, Phillips M, Price R, Patrikeos AP, Musk AW, Millward MJ.

J Nucl Med. 2007 Sep;48(9):1449-58. Epub 2007 Aug 17.

42.

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.

Mayer A, Francis RJ, Sharma SK, Tolner B, Springer CJ, Martin J, Boxer GM, Bell J, Green AJ, Hartley JA, Cruickshank C, Wren J, Chester KA, Begent RH.

Clin Cancer Res. 2006 Nov 1;12(21):6509-16.

43.
44.

Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT).

Francis RJ, Mather SJ, Chester K, Sharma SK, Bhatia J, Pedley RB, Waibel R, Green AJ, Begent RH.

Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1090-6. Epub 2004 Mar 17.

PMID:
15029458
45.

Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis.

Gold EJ, Francis RJ, Zimmermann A, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Wheatley AM, Fleming JS.

Mol Cell Endocrinol. 2003 Mar 28;201(1-2):143-53.

PMID:
12706302
46.

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.

Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbins A, Gumbrell L, O'Malley D, Tsiompanou E, Shahbakhti H, Webley S, Hochhauser D, Hilson AJ, Blakey D, Begent RH.

Br J Cancer. 2002 Sep 9;87(6):600-7.

47.

Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin.

Sebire NJ, Foskett M, Paradinas FJ, Fisher RA, Francis RJ, Short D, Newlands ES, Seckl MJ.

Lancet. 2002 Jun 22;359(9324):2165-6.

PMID:
12090984
48.
49.

The First Organically Templated Open-Framework Niobium Silicate and Germanate Phases: Low-Temperature Hydrothermal Syntheses of

Francis RJ, Jacobson AJ.

Angew Chem Int Ed Engl. 2001 Aug 3;40(15):2879-2881. No abstract available.

PMID:
11500895
50.

The First Organically Templated Open-Framework Niobium Silicate and Germanate Phases: Low-Temperature Hydrothermal Syntheses of [(C4 N2 H11 )Nb3 SiO10 ] (NSH-1) and [(C4 N2 H11 )Nb3 GeO10 ] (NGH-1).

Francis RJ, Jacobson AJ.

Angew Chem Int Ed Engl. 2001 Aug 3;40(15):2879-2881. doi: 10.1002/1521-3773(20010803)40:15<2879::AID-ANIE2879>3.0.CO;2-G.

PMID:
29711985

Supplemental Content

Loading ...
Support Center